Hua X, Church K, Walker W, L'Hostis P, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial. J Alzheimers Dis 2022 Feb 18. pii: JAD215511. doi: 10.3233/JAD-215511.
PMID: 35180125